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Fetal alcohol spectrum disorders (FASD) are a group of related conditions that arise
from prenatal exposure to maternal consumption of the teratogen, ethanol. It has been
estimated that roughly 1% of children in the US suffer from FASD (Sampson et al., 1997),
though in some world populations, such as inhabitants of some poorer regions of South
Africa, the rate can climb to as high as 20% (May et al., 2013). FASD are the largest cause
of mental retardation in U.S. neonates, and ironically, are entirely preventable. FASD have
been linked to major changes in the hypothalamic-pituitary-adrenal (HPA) axis, resulting
in lifelong impairments through mental disorders, retardation, and sensitivity to stress.
FASD are linked to an impaired immune system which consequently leads to an elevated
risk of cancer and other diseases. FASD arise from a complex interplay of genetic and
epigenetic factors. Here, we review current literature on the topic to tease apart what is
known in these areas particularly emphasizing HPA axis dysfunction and how this ties into
new studies of transgenerational inheritance in FASD.
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INTRODUCTION
A negative impact from alcohol consumption has been observed
since ancient times, leading to cultural prohibitions on alcohol
consumption, particularly among women of childbearing years.
The ancient Greeks demonstrated some awareness of the risks
of alcohol consumption – for example, Plato proposed limiting
wine consumption in people under 40 years of age (Abel, 1984).
In some ancient societies, such as the Carthaginian Empire, the
prohibitions were even written into law (Jones et al., 1973; Abel,
1984). Biblical and Talmudic references suggest that possibly, the
ancientHebrewsmight have had some awareness that alcohol con-
sumption among fathers and mothers prior to conception could
be harmful to the offspring (Abel, 1984). Ancient Vedic writ-
ings list prohibitions for drinking by Brahmins (Sharma et al.,
2010) suggesting recognition of some negative effects of alco-
hol, though it is not clear whether an impact on offspring was
known. Many sources discussing parental alcohol consumption
before modern times focused upon paternal consumption more
than maternal (Abel, 1984). With the writings of Francis Bacon in
1627, we see deﬁnite concerns about the impact of maternal alco-
hol consumption on offspring, and in the early 18th century in
England, the “gin epidemic” gave rise to commentary that drink-
ing speciﬁcally during pregnancy harmed the developing child
(Abel, 1984).
Studies in guinea pigs a century ago found that not only did
paternal chronic alcohol consumption result in higher mortality
rates of offspring, but that the mortality rate was elevated even
in the grandchildren of the alcohol-consuming father (Stockard,
1913), giving the ﬁrst known evidence of a potential multigener-
ational effect of alcohol exposure. Fetal alcohol syndrome (FAS),
the more severe manifestations of the FASD, ﬁrst began to appear
in the medical literature in 1973 (May and Gossage, 2011), and
research in the ﬁeld of fetal alcohol exposure began to take off
as the research community launched a coordinated effort into
understanding FASD. This led to the recent discovery of a trans-
generational impact of fetal alcohol exposure upon stress axis
dysfunction. This impact was discovered to be mediated by epige-
netic mechanisms carried speciﬁcally in the male germline of rats
(Govorko et al., 2012).
DYSREGULATION OF THE HPA AXIS IN FETAL ALCOHOL EXPOSED
OFFSPRING
The fetal stage of human life is arguably the most susceptible to
harm from alcohol as the fundamental development of organs and
pathways occurs in this stage. Not surprisingly, mothers who con-
sume alcohol despite the risks may create severe developmental
problems in their offspring. FASD, as its name implies, comprises
a wide range of mental, emotional, craniofacial, physiological,
and immune disorders which arise from maternal consumption
of alcohol. In general, severity of the disorder correlates with the
degree of maternal alcohol consumption, though some individu-
als are more resistant to the effects than others. Individuals with
milder forms of FASD may not show any obvious deformities, but
may be affected with hyperactivity, depression, anxiety or other
disorders that impair quality of life (Schneider et al., 2002). At the
other end are individuals with visible deformities, severe retarda-
tion, an impaired immune system, impaired metabolic function,
and lifelongproblems copingwith stress, individualswhohave FAS
(Momino et al., 2012). At the molecular level, many intertwined
causal factors contribute to FASD leading to the varied impacts
seen among those who suffer. Among the factors, FASD is inti-
mately tied to hyperstress-response and anxiety disorders that are
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connected to the dysregulation of hypothalamic-pituitary-adrenal
(HPA) axis functions.
The HPA axis is a complex neuroendocrine loop main-
tained by crosstalk between the hypothalamus, pituitary, and the
peripheral adrenal glands. The paraventricular nucleus (PVN)
of the hypothalamus generates corticotrophin-releasing hormone
(CRH) and vasopressin, stimulating the production of the pre-
cursor polypeptide proopiomelanocortin (POMC) in the ante-
rior lobe of the pituitary. The breakdown of POMC releases
adrenocorticotropic hormone (ACTH) initiating the delivery of
glucocorticoids (GCs) to peripheral circulation from the adrenal
glands. The primary GC produced in the human adrenal cor-
tex is cortisol (corticosterone in rats). Corticosterone can inhibit
the production of POMC in the anterior lobe of the pituitary
in rats, creating a feedback loop (Eberwine and Roberts, 1984).
GCs reduce inﬂammatory responses through an immunosup-
pressive action, and stimulate the sympathetic “ﬁght or ﬂight”
response giving a rapid, temporary boost to an organism respond-
ing to an environmental threat. The autonomic nervous system
complements the stress response, either through “ﬁght or ﬂight”
(mentioned above), or by “tend and mend,” an opposing process
through the parasympathetic nervous system. ACTH also stimu-
lates the production of catecholamines (CATs) from the adrenal
glands. Epinepherine, also known as adrenaline, and its coun-
terpart, norepinephrine (noradrenaline) are CATs released by the
adrenalmedulla that activate the sympathetic stress response, lead-
ing to many of the common physiological symptoms of stress,
such as sweating, dry mouth, and a rapid heartbeat. Though
the sympathetic stress response increases survival, it comes at a
signiﬁcant cost in terms of metabolism, the immune system, diges-
tion, and other physiological processes, and cannot be maintained
indeﬁnitely (reviewed in Rachdaoui and Sarkar, 2013; Wynne and
Sarkar, 2013).
β-endorphin is another peptide product of POMC generated
through the stress response. β-endorphin is an opioid that can
regulate pain, but it also regulates ACTH (another peptide prod-
uct of POMC; Fratta et al., 1981) and corticotrophin-releasing
hormone (CRH; Plotsky, 1986). Hypothalamic β-endorphin is
important to the homeostasis of the stress response. CRH and
catecholamines stimulate β-endorphin release that suppresses the
HPA axis response (Boyadjieva et al., 2009). δ and μ opioid recep-
tors bind central β-endorphin, regulating the autonomic nervous
system through the PVN. Levels of pituitary β-endorphin have a
smaller role on the autonomic nervous system and are regulated
by arginine vasopressin (AVP) and CRH (reviewed by Sarkar et al.,
2012).
Proopiomelanocortin neurons in the arcuate nucleus of the
hypothalamus play a critical function in regulation of the HPA
axis as well as reward pathways and the immune system, through
the neuropeptidesmelanocortin,ACTH,and β-endorphin derived
from the POMC precursor polypeptide (Sarkar et al., 2012).
POMC neuronal functions were found to be impaired in fetal
alcohol-exposed (FAE) rats (Sarkar et al., 2007; Hellemans et al.,
2008; Boyadjieva et al., 2009). Recent experiments showed that
replacing β-endorphin/POMC-producing cells in FAE rats led to
an improvement in stress and immune response in the animals,
demonstrating a role for POMC in FASD (Boyadjieva et al., 2009).
VARIANT ALLELES OF GENES INVOLVED IN DEVELOPMENT,
THE HPA AXIS, AND ALCOHOL METABOLISM PLAY A
STRONG ROLE IN FASD SUSCEPTIBILITY AND SYMPTOMS
Though studies showing heritable damage from fetal alcohol expo-
sure go back at least a century (Stockard, 1913), it was only with
the use of molecular biology approaches during the 1980s that
science began to unravel the genetic underpinnings of FASD. At
the chromosomal level, structural damage was observed at a high
frequency among prenatally exposed individuals in a clinical set-
ting. In one study, 8.75% (7/80) of FASD patients in a genetic
screening were determined to have chromosomal abnormalities,
typically microduplications or microdeletions (Douzgou et al.,
2012). Strong evidence for a genetic component to FASD includes
a comparison between mono- and dizygotic twins. Monozygotic
twins (having the same genome) show 100% concordance for
FASD; that is, if 1 twin has FASD, the other will also have FASD. In
comparison, dizygotic twins (having genomes that are moderately
different) show only 63% concordance (Streissguth and Dehaene,
1993), showing that even the modest genetic differences of siblings
sharing the same environment lead to a signiﬁcantly different rate
of susceptibility to FASD.
It is known that multiple genetic loci are affected by alco-
hol, with each variant allele interacting in a complex biological
pathway with other genes (Johnson et al., 2006). In FASD, this
complexity is multiplied as the genes of the mother can impact
the fetal environment and expression of genes of the develop-
ing fetus, shaping its susceptibility toward fetal alcohol exposure.
Maternal RNA and proteins are present in the oocyte to allow
for development to occur in the early embryo until it has devel-
oped to the Maternal-to-Zygotic transition (MZT) at which point
the embryonic cellular processes take over (Schier, 2007). Mater-
nal hormones have also been shown to play an important role in
development of an offspring. These examples show that mater-
nal genes (and their products) can have a strong impact on the
development of the fetus beyond contribution of genes alone,
dubbed the “maternal effect.” By contrast, transmission of a
phenotype from the father passed through the father’s sperm
(“paternal effect”) is more limited but has been demonstrated
(Fitch et al., 1998). In short, altered parental expression of impor-
tant genes could result in signiﬁcant vulnerability or resistance
of the offspring to ethanol-induced dysregulation in embryonic
development even in the absence of those genes in the child, lay-
ing down a dysfunctional or more resistant foundation that lasts a
lifetime.
A number of genes have also been identiﬁed as potentially
playing a direct role in FASD. In a study of rhesus monkeys, it
was demonstrated that fetal monkeys carrying a short serotonin
transporter gene polymorphic region variation (rh5-HTTLPR),
an allele with a functional analog in humans, were particularly
susceptible to prenatal alcohol exposure during early gestation,
leading to sensory disorders (Schneider et al., 2009). Prior studies
indicated that this allele was linked to a greater incidence of irri-
tability and stress-responsiveness in monkey offspring subjected
to prenatal alcohol exposure (Kraemer et al., 2008).
Genes coding for alcohol dehydrogenase variants have been
found to be particularly relevant for FASD, sometimes result-
ing in varied incidence or severity of FASD. In some cases, they
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may alter maternal drinking patterns: ADH variants have been
linked to alcohol addiction, while other variants may cause moth-
ers to drink less. Alcohol dehydrogenases are found ubiquitously
across the kingdoms of living organisms. The products of these
genes are involved in converting alcohols (ROH) into aldehydes
(R-CHO) and ketones (RCOR’) through reduction of the coen-
zyme nicotinamide adenine dinucleotide (NAD+) into NADH.
Humans have six differentADHs, and alcohol dehydrogenase plays
an important role in ethanol metabolism and alcohol addiction.
Slower metabolizing variants of ADH2 and -3 have been linked
to alcoholism in Asian populations (Osier et al., 1999). ADH1B
has a strong link to alcoholism (Li et al., 2011). In FASD, it was
discovered that maternal variant alleles of ADH1B, ADH1B∗2,
and ADH1B∗3 (both relatively common in African-descended
populations) which metabolize alcohol rapidly, led to reduced
incidence of FASD in offspring, even those without the gene
(Warren and Li, 2005; Jacobson et al., 2006). It is known that
ADH1B∗3 leads to reduced alcohol intake, so possibly it creates
an unpleasant association with elevated aldehyde levels through
rapid metabolization of alcohol, or the enzyme could help pro-
tect offspring by reducing the peak blood alcohol levels, a critical
factor in determining the amount of damage done to fetuses
(Jacobson et al., 2006), suggesting that these could be underly-
ing mechanisms for reducing the incidence of FASD. In fetal
mice exposed to alcohol, variant genotypes of aldh2, an alco-
hol dehydrogenase gene, have been linked to defects in brain
development and vision. This was exacerbated in mice lacking
fancd2, which plays a downstream role in processing aldehyde
metabolites of alcohol (Langevin et al., 2011). In zebraﬁsh, mars
(a gene involved in alcohol metabolism) null ﬁsh were linked
to developmental face and brain dysfunction during an embry-
onic alcohol study (McCarthy and Eberhart, 2014). Other genes
impacted by ethanol in an embryonic alcohol study conducted
in zebraﬁsh include hinfp, plk1, foxd1, and vangl2, which have
signiﬁcance in cellular processes such as translation and the
cell cycle, and in early development (McCarthy and Eberhart,
2014). Bioinformatic data mined from the results of published
literature searches identiﬁed from a screen of over 10,000 can-
didate genes, a subset of 87 genes within the TGF-β, MAPK,
and Hedgehog signaling pathways which were likely relevant for
FASD. These include gnas, and msx1, important in apoptosis
and cell signaling, fgfr1-3, important for embryonic bone devel-
opment, and bmp4, important in myogenesis. Also included
were foxg1b, hoxa1, and pax6, important in brain development
(Lombard et al., 2007). These genes were examined through path-
way, protein-protein and transcription binding analysis and are
rich targets for studies into the genetics of FASD. They also
ﬁt well with observed phenotypic changes in FASD patients
including facial deformities, cardiovascular irregularities, skele-
tal defects, and brain growth defects (Clarren et al., 1978; Clarren,
1986).
In summary, many genes, either related to alcohol metabolism,
or to development and the HPA stress axis, have been identiﬁed in
relation to FASD.Variants of some of these genes have been shown
to contribute to the varied responses seen to fetal alcohol exposure,
and it seems likely that other genes also contribute. This may
explain in part why the percentage of women who drink during
pregnancy is so much higher than the percentage of children who
are born with FASD.
FETAL ALCOHOL EXPOSURE CAUSES EPIGENETIC CHANGES
CRITICAL TO FASD
Epigenetics refers to changes in gene expression that do not arise
from changes in the underlying DNA sequence. Environmental
toxins such as ethanol may impact the expression of genes through
altering DNA methylation patterns or modifying histone tails by
methylation or acetylation. Epigenetic studies related to FASD are
still an emerging ﬁeld (Haycock, 2009) but have led to the dis-
covery that many symptoms of FASD can be traced back at least
in part to aberrant epigenetic marks laid down during gamete
production, or during embryonic development under the inﬂu-
ence of alcohol. Recent studies have found epigenetic changes
due to ethanol that are permanent (Govorko et al., 2012), and
they can act broadly across the genome (Kaminen-Ahola et al.,
2010). Both DNA methylation and histone modiﬁcations, two of
the most commonly studied epigenetic mechanisms, can alter the
accessibility of DNA to the molecular transcriptional machinery,
providing a powerful method for ethanol to create developmen-
tal havoc through changing the expression of genes (Renthal and
Nestler, 2009).
DNA METHYLATION
The process of DNA methylation involves the transfer of a methyl
group by a DNA methyltransferase (DNMT), utilizing S-adenosyl
methionine (SAM), to the C5 carbon of a cytosine residue, typ-
ically in regions containing strings of CpG dinucleotides (CpG
islands; Bestor,2000). CpG islands (CGIs) are traditionally deﬁned
by having an extended stretch of nucleotides (>200 bases), a
C/G nucleotide composition above 50%, and an observed CpG
dinucleotide content of 65+% (Gardiner-Garden and Frommer,
1987). Roughly 70% of annotated promoters show the presence
of CGIs that either contain transcription start sites (TSS) or are
near them (Saxonov et al., 2006). In vertebrates, CpGs are in low
overall abundance and often methylated, however, CpGs in CGIs
are frequently unmethylated (Deaton and Bird, 2011). Approxi-
mately half of CGIs in mice and humans are associated with TSS
(Illingworth et al., 2010; Deaton and Bird, 2011). The remaining,
dubbed “orphan CGIs” are themselves often associated with novel
promoters (Illingworth et al., 2010; Maunakea et al., 2010).
Methylation of CpG islands is often regulated during devel-
opment to control gene expression and the level of methylation
correlates with the magnitude of gene inactivation (Doerﬂer,
1983).
Alcoholmay affect DNAmethylation through an impact on key
methylating enzymes such as DNA methyltransferases (DNMTs).
Studies have shown that a downstream metabolite of alcohol
breakdown, acetaldehyde, can inhibit DNMT1 (Garro et al., 1991).
DNA methylation changes can also occur by altering the intercon-
nected choline, methionine and 5-methyltetrahydrofolate (folate)
pathways, which provide key substrates for methylation (Hamid
et al., 2009). Alcohol exposure may act through folate (Hidiroglou
et al., 1994) and S-adenosylmethionine (SAM; Barak et al., 1993;
Lu et al., 2000). Alcohol reduces the absorption of folate from the
diet, a vitamin that is necessary for carbon-transfer reactions in
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the methionine–homocysteine pathway, putting limits on DNA
methylation (Halsted et al., 2002). Folate deﬁciency is linked to
global DNA hypomethylation (Kim et al., 1997). Choline supple-
mentation reduces FASD symptomsby providing sufﬁcientmethyl
groups to the methinone–homocysteine pathway (Thomas and
Tran, 2012; Bekdash et al., 2013; Wozniak et al., 2013).
Alcohol-mediated aberrant methylation has been documented
in at least several developmental genes in alcohol-abusing humans
(Bönsch et al., 2006; Hillemacher et al., 2009). In addition, alco-
hol can act through demethylation (Ponomarev, 2013). DNA
methylation changes have been observed to occur during early
development. Liu et al. (2009) found that extensive methyla-
tion occurred in developmental genes of alcohol-exposed mouse
embryos (Liu et al., 2009). Kaminen-Ahola et al. (2010) found that
the Avy gene in mice was hypermethylated following alcohol expo-
sure in early fetal development. Prenatal alcohol exposure studies
in mice demonstrated DNA methylation changes resulting in neu-
rofacial and growth defects analogous to FASD in humans (Liu
et al., 2009). Alcohol exposure alters DNA methylation proﬁles
in mouse embryos at early neurulation and alters methylation of
imprinted genes, known to play roles in the cell cycle, growth,
apoptosis, cancer, and in a large number of genes associated
with olfaction. These results indicate that gene speciﬁc and global
changes in DNA methylation occur in response to alcohol during
fetal development.
Exposures to ethanol and other toxicants during critical win-
dows in development can be particularly damaging and can cause
epigenetic changes in gene expression of the brain that impact
the brain for the life of the organism (Kobor and Weinberg, 2011;
Ungerer et al., 2013; Nestler, 2014). Alcohol is highly damaging
before and during very early development, speciﬁcally at three
events. When gametes are being produced or are maturing, they
are vulnerable to alcohol abuse (Haycock, 2009) as demonstrated
by several studies (Ouko et al., 2009; Govorko et al., 2012). This
is likely because DNA is being actively repackaged during this
period. Also germ cells persist for extended periods of time in
the body, providing a longer window for the actions of repeated
exposures to environmental toxins like ethanol. A second highly
vulnerable period occurs after fertilization but before implanta-
tion,when the embryo is undergoing rapid developmental changes
and is preparing for implantation. The third occurs at gastrula-
tion, when the three germ layers are being deﬁned. As a result,
histone marks are being laid down to specify cell types (Shi and
Wu, 2009), and the developing embryo is at its most vulnerable
to alcohol at this stage (Armant and Saunders, 1996; Haycock,
2009).
Rat-based studies have found that POMC expression is affected
by fetal alcohol exposure, leading to the loss of β-endorphin pro-
ducing neurons and a reduction in POMC expression (Chen et al.,
2006; Sarkar et al., 2007; Kuhn and Sarkar, 2008). It has been found
that ethanol is able to increase DNA methylation of the promoter
region of POMC in fetal pups, changing the epigenetic markings
to downregulate POMC expression (Govorko et al., 2012). This
is important as POMC neurons, located in the hypothalamus,
are critical for bringing stress homeostasis. The perturbation of
the HPA axis is a direct cause of many of the symptoms associ-
ated with FASD including deﬁcient stress response, depression,
anxiety, and impaired immunity (Sarkar, 1996; Pritchard et al.,
2002; Rafﬁn-sanson et al., 2003; Sarkar et al., 2012; Rachdaoui and
Sarkar, 2013).
In short, DNA methylation has been found to be a strong factor
in the incidence of FASD. Alcohol acts through several routes to
affect DNA methylation, and seems to be particularly damaging at
speciﬁc stages of embryonic development resulting in signiﬁcant
changes in methylation that can last a lifetime.
HISTONE MODIFICATION
Histone modiﬁcations are other major biological processes by
which epigenetic modiﬁcation of gene expression occurs. DNA
is wound around histones, affecting its ability to interact with
transcriptional machinery. Tight packaging results in less interac-
tion. Covalent modiﬁcations to the tails of histones 3 and 4 (H3
and H4) are commonly studied. However, H3 and H4 are not the
only histones that can be epigenetically modiﬁed. For H3 and H4,
heterochromatin, the silenced state, is associated with hypoacety-
lation (de-acetylated state), and di- or trimethylation of the nineth
lysine residue on H3 (H3K9me2 or H3K9me3). The open state,
euchromatin, is associated with acetylated H3 and H4, and di- or
tri-methylation of the fourth lysine residue of H3 (H3K4me2 or
H3K4me3; Arney and Fisher, 2004). Thus, histone methylation,
depending on the target of methylation, can result in a change in
expression in either direction. There can be coordinated regulation
between histone modiﬁcations and other epigenetic mechanisms,
including DNA methylation (Jin et al., 2011).
Histone marks have been linked to alcohol consumption (Pal-
Bhadra et al., 2007; Pandey et al., 2008). Alcohol causes histone
marks to occur in speciﬁc genomic locations (Kim and Shukla,
2006). Usually in alcohol studies this has been H3K4me3 (Histone
3 Lysine 4 residue, trimethylated) and acetylation/deacetylation of
H3 and H4 (Ponomarev, 2013). Govorko et al. (2012) found that
histone deacetylation occurred in fetal rat pups exposed to ethanol,
leading to decreased expression of POMC, which partly explains
the subsequent disruption of the HPA axis and FASD symptoms
observed. See Figure 1 for a summary of current knowledge.
A number of studies into the impact of ethanol on develop-
ment have been conducted using cell culture models. Cardiac
development was affected by ethanol using cardiac progenitor
cells. Under ethanol exposure, it was found that heart devel-
opment was signiﬁcantly affected, and H3 acetylation ensued.
The effect was dose dependent, leading to greater gene expres-
sion changes in higher ethanol doses (Zhong et al., 2010). In fetal
neuronal stem cell neurospheres, ethanol was observed to remove
histone methylation marks from promoters (either H3K4me3 and
H3K27me3, or both) across 20 candidate genes playing roles
in processes such as the regulation of neural stem cell biol-
ogy, and neural patterning (Veazey et al., 2013). Ethanol also
impacted the ES-like bivalent signature of the cells (Veazey et al.,
2013). Interestingly, for most genes transcriptional control was
not changed by the change in histone modiﬁcations (Veazey et al.,
2013).
By itself, studies of H3K4me3methylation in relation to alcohol
exposure have been found to not be a good predictor of expres-
sion (Ponomarev, 2013). Some recent ﬁndings have suggested that
global chromatin modiﬁcations in relation to drug exposure tend
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FIGURE 1 |The impact of fetal alcohol exposure on the
hypothalamic-pituitary-adrenal (HPA) axis. Fetal alcohol exposure
increases DNA methyltransferase activity to methylate CpGs in the
promoter of the POMC gene in the hypothalamus and activates histone
deacetylases to remove acetyl groups from histones in the proximity of
the POMC gene. Both methylation and deacetylation lead to the
repression of POMC gene transcription. This results in reduced
production of β-endorphin, a peptide derived from POMC gene, in the
hypothalamus. Reduced β-endorphin production disrupts the normal
feedback regulation of the HPA axis causing hyper-response of CRH
following stress and subsequently, increased secretion of ACTH from
the anterior pituitary and glucocorticoids (corticosterone in rats and
cortisol in humans) from the adrenal gland. In fetal alcohol-exposed rats,
the HPA axis is dysregulated resulting in hyperstress-response, mental
dysfunction, and an impaired immune system. POMC gene
hypermethylation and its subsequent impact on the HPA axis persist for
a minimum of three generations of progeny, carried through the male
germline.
to be transient, and revert back to “normal” states within hours to
days after the toxicant is removed suggesting that global changes
may not be informative (Nestler, 2014). Though transient in some
studies, if damage from aberrant methylation occurs at critical
windows such as during fetal development when fundamental
structures are being laid down, then at least some of the effects
could be permanent.
Epigenetic modiﬁcations such as those described above have
been linked to many diseases, including major mental disorders
such as depression, schizophrenia, bipolar disorder (“manic-
depression”), and addiction (Jaenisch and Bird, 2003; Eger et al.,
2004; Hsieh andGage, 2005; Sharma et al., 2008; Maze andNestler,
2011). Haley et al. (2006) found that the HPA stress axis in infants
was impacted from fetal alcohol exposure, likely due to epigenetic
changes during gastrulation. Given the links between the HPA
axis, FASD and mental disorders, understanding the dysregulation
of POMC through epigenetic mechanisms could lead to a better
understanding of these diseases and new avenues of treatment.
MicroRNAs
MicroRNAs (miRNAs) are a class of non-coding RNAs. They are
roughly 22nt in length and function primarily by targeting the 3′
untranslated region (UTR) of transcripts, leading to their down-
regulation. MiRNAs increasingly have been found to be important
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post-transcriptional gene regulators involved in many biological
processes widely across animals and most kingdoms (Reviewed
in Berezikov, 2011). The effects of microRNAs in fetal alcohol
exposure can occur both at the genetic level and at the level of epi-
genetics. MiRNA expression has been observed to vary between
individuals, leading to changes in predisposition to, and sever-
ity of, diseases (Chu et al., 2012; Lukiw, 2013). In some cases,
single nucleotide polymorphisms (SNPs) in the genes coding for
miRNAs impact their expression and function (Sun et al., 2009).
These individual differences could lead to signiﬁcant differences
in the consequences to offspring under maternal alcohol con-
sumption. Alternatively, microRNA expression can be modiﬁed
through epigenetic mechanisms by ethanol (Miranda, 2012), and,
as microRNAs interact directly with epigenetic machinery at mul-
tiple levels (reviewed in Singh and Campbell, 2013), it seems likely
that maternal ethanol consumption could also affect DNA methy-
lation and histone acetylation/deacetylation via microRNAs. As
miRNAs have been implicated in FASD models in rodent studies,
particularly in neural development (Wang et al., 2009; Miranda,
2012), changes to miRNA expression likely have a signiﬁcant
role in FASD development in the children of women who abuse
alcohol.
There is also evidence of miRNA interaction with the HPA
stress axis. Recently, it was demonstrated in mice that paternal
stress could impact the HPA stress axis, via epigenetic mech-
anisms acting on DNA in sperm to transmit heritable changes
(Rodgers et al., 2013). Among the microRNAs in the list of those
impacted by paternal stress which interact with theHPA stress axis,
the expression of miR-29c and miR-204 were found to change in
expression due to alcohol exposure in adult rat prefrontal cortex
(PFC; Tapocik et al., 2013), whereas miR-29c and -30a were found
to be altered in fetal mouse brains during exposure to maternal
ethanol (Wang et al., 2009), suggesting that these microRNAs may
impact HPA axis development during fetal alcohol exposure.
TRANSGENERATIONAL EPIGENETIC INHERITANCE OF FASD
SYMPTOMS
HERITABLE EPIGENETIC MODIFICATIONS PLAY A ROLE IN MANY
DISEASES
Transgenerational epigenetic inheritance, changes carried through
the germline (Guerrero-Bosagna et al., 2010; Thornburg et al.,
2010), provides an explanation for questions that molecular biol-
ogists have not been able to answer through genetics alone.
Heritable epigenetic modiﬁcations play a key role in some human
diseases. Several syndromes in the literature include Angelman,
Prader-Willi, and Beckwith-Wiedemann syndrome. These are
linked to heritable changes, such as deletions, in speciﬁc chromo-
some regions that undergo genomic imprinting (Adams, 2008).
In imprinting, parental differences in epigenetic modiﬁcations of
speciﬁc genes occur in sperm and ova, resulting in parent-speciﬁc
gene expression. When the contribution to a gene from one parent
is silenced through epigenetic mechanisms, deleting the copy from
the other parent results in loss of the gene function.
TRANSGENERATIONAL EPIGENETIC MODIFICATIONS ARE RARE
Transgenerational epigenetic marks on genes are less common
than transient marks as most epigenetic signatures are typically
lost during gametogenesis. In some cases, certain marks may be
retained due to a bias in removal (Morison andReeve, 1998). Some
genes continue to show parental methylation of promoter regions
(Borgel et al., 2010). Many epigenetic marks are removed at meio-
sis (Bond and Finnegan, 2007), and the DNA is methylated again
by during early development, often to mark cell type speciﬁcity
(Shi and Wu, 2009), as there are over 200 different cell types in the
body (Alberts et al., 2002).
Prior to fertilization, the male gamete carries the father’s
germline epigenetic signature. However, when fertilization occurs,
most of the male’s epigenetic marks are lost. Late in the produc-
tion of sperm, protamines condense the paternal DNA, protecting
it and replacing most histones. However, not all histones are
replaced; some histones that remain will keep their prior epi-
genetic marks (Hammoud et al., 2009; Brykczynska et al., 2010).
During the interaction of sperm and egg, after the nuclear mem-
branes fuse and the sperm DNA is deposited, the protamines are
lost, replaced with histones from the egg. The DNA from the
male enters a more open state- most of the replacing histones are
acetylated and the much of the methylation present in the DNA
is removed (Oswald et al., 2000; Fulka et al., 2004). Interestingly,
some regions seem to be protected from demethylation including
imprinted genes (Li, 2002). Following fusion, maternal enzymes
re-methylate signiﬁcant regions of the sperm DNA.
Transgenerational epigenetic effects due to exposure to haz-
ardous chemicals have been documented for 4 ormore generations
(Anway et al., 2005). To be considered a transgenerational epige-
netic effect, the effect must persist for multiple generations. The
number of generations required to demonstrate a transgenera-
tional epigenetic effect differs, depending on whether the effect is
maternally or paternally transmitted. For maternal transmission,
three affected generations of offspring are required to demon-
strate a transgenerational epigenetic effect. This is because the
fetus (F1) inside the mother (F0) is developing gonads (which
give rise to the F2 generation), so a purely environmental effect
could in theory directly impact the grandchild through alterations
to the gonads of F1, leading to a multigenerational effect, but
not demonstrating heritable epigenetic transmission. Therefore,
to demonstrate persistence of the effect, three generations (F3)
of progeny must be impacted. For paternal transmission, the
minimum number of impacted generations is two; that is the
grandchild of the founder. Sperm could be directly impacted
by an environmental agent, leading to an impact on the F1 off-
spring, but it would require an epigenetic mechanism to then
transmit this effect to the F2 generation (Jirtle and Skinner,
2007).
TRANSGENERATIONAL EPIGENETIC MODIFICATIONS CAUSED BY
MATERNAL ALCOHOL CONSUMPTION CAN PROCEED THROUGH THE
MALE GERMLINE
There are a number of multigenerational demonstrations of the
heritability of alcohol-related disorders in the literature. In a
recent study of Native American women who abused alcohol, F2
generation offspring (that is the grandchildren) of an alcohol-
abusing woman have a higher tendency to show FAS than those
who do F2 progeny of control women (Kvigne et al., 2008).
Recently, Govorko et al. (2012) showed that following in utero
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exposure to ethanol, regulatory regions of POMC in the hypotha-
lamus of rats undergo epigenetic modiﬁcations: altered histone
marks and DNA methylation of the proximal promoter. In addi-
tion, histone modifying HDACs and DNA methyltransferases
(DNMTs) were shown to be impacted, suggesting a causal rela-
tionship between alcohol and epigenetic changes. As a result,
POMC neurons are impacted across at least three generations,
perturbing the expression of key POMC-derived peptides such
as β-endorphin, and affecting the production of its downstream
messenger corticosterone leading to dysregulation of the HPA axis
and an elevated response to stress in the adult offspring. This
was the ﬁrst demonstration of a true transgenerational epige-
netic effect for prenatal alcohol exposure. Interestingly, Govorko
et al. (2012) were able to reverse this effect through HDAC and
DNA methylation inhibitors, providing additional support for
their conclusion.
There is also evidence that hypomethylation occurs in the
sperm of alcoholic men (Ouko et al., 2009). Transmission of
the effects of alcohol through the male germline has precedents
in the literature for induction of symptoms like those found in
FASD. These include mental impairment, cardiac defects, low
birth weight, and hyperactivity, compared to controls, as assessed
in human epidemiological studies and backed by animal studies
(Abel, 2004). This supports the ﬁndings of Govorko and colleagues
that factors that impact POMC and subsequently affect the HPA
axis and FASD, can be transmitted by males through the germline.
SUMMARY AND FUTURE DIRECTIONS
FASD is caused by a complex interaction of genes and environ-
ment, and is regulated by both parental and fetal genes. Some
symptoms of FASD are caused by decreased expression of POMC,
and it’s peptide product,β-endorphin, important in theHPA stress
axis regulation. Recent studies by Govorko et al. (2012) have elu-
cidated that POMC epigenetic changes are transmitted through
pups in the male germline descended from fetal alcohol exposed
animals for several generations. It is currently unknown how this
occurs, as direct changes to the enzymes involved in methyla-
tion and deacetylation should also impact female progeny. It is
speculated that the non-pairing region of the Y chromosome,
which is euchromatic, may be partly protected from demethy-
lation and could carry the epigenetic modiﬁcations to future male
progeny.
The reversibility of the POMC system defect that Govorko and
colleagues demonstrated via themodulation of the components of
the epigenetic machinery may have therapeutic potential. Histone
deacetylase inhibitors have proven to be effective in reducing some
symptoms of alcohol damage. These act by preventing HDACs
from removing acetyl groups from the tails of histones, and ulti-
mately maintain a potentially transcriptionally active state. Rat
studies have shown that this can improve the symptoms of FASD
(Govorko et al., 2012), and also can function to prevent tolerance
and withdrawal in adult rats (Sakharkar et al., 2012).
Choline inﬂuences SAM levels, and choline deﬁciency dur-
ing development phenotypically mimics folate deﬁciency (Zeisel,
2004, 2006). Choline chloride supplementation has been suc-
cessful in reducing the impact of maternal alcohol consumption
on developing fetuses (Thomas et al., 2007, 2010; Bekdash et al.,
2013). The use of choline and HDAC or DNMT inhibiting
supplements to mitigate FAS symptoms in rats suggests that sup-
plementation could assist at-risk populations during pregnancy,
though more studies need to be done in this area. In addi-
tion, developments in the understanding of epigenetic regulation
of POMC may suggest additional treatment strategies to reduce
symptoms of the illness related to theHPA stress axis in adults, and
given the links to other disorders, such as cancer and mental disor-
ders, the effects of this research could be far-reaching. The future is
promising.
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